307 related articles for article (PubMed ID: 21849257)
1. Immunohistochemical expression of ezrin in cutaneous basal and squamous cell carcinomas.
Abdou AG; Maraee AH; El-Sayed EM; Elnaidany NF
Ann Diagn Pathol; 2011 Dec; 15(6):394-401. PubMed ID: 21849257
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical galectin-3 expression in non-melanoma skin cancers.
Kapucuoglu N; Basak PY; Bircan S; Sert S; Akkaya VB
Pathol Res Pract; 2009; 205(2):97-103. PubMed ID: 18951731
[TBL] [Abstract][Full Text] [Related]
4. Greater expression of TC21/R-ras2 in highly aggressive malignant skin cancer.
Lee JH; Pyon JK; Lee SH; Lee YJ; Kang SG; Kim CH; Kim DW; Nam HS; Park YH; Jeong DJ; Cho MK
Int J Dermatol; 2011 Aug; 50(8):956-60. PubMed ID: 21781067
[TBL] [Abstract][Full Text] [Related]
5. Significance of PC cell-derived growth factor and cyclin D1 expression in cutaneous squamous cell carcinoma.
Huang K; Huang C; Shan K; Chen J; Li H
Clin Exp Dermatol; 2012 Jun; 37(4):411-7. PubMed ID: 22420613
[TBL] [Abstract][Full Text] [Related]
6. Maspin expression in normal skin and usual cutaneous carcinomas.
Reis-Filho JS; Torio B; Albergaria A; Schmitt FC
Virchows Arch; 2002 Dec; 441(6):551-8. PubMed ID: 12461611
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptor-2 expression in basal and squamous cell carcinomas compared with normal skin.
Dastgheib L; Monabati A; Mohammadian A; Sari-Aslani F; Marzban S; Namazi MR
J Cutan Pathol; 2009 Mar; 36(3):314-7. PubMed ID: 19032384
[TBL] [Abstract][Full Text] [Related]
8. GLUT-1 Expression in Cutaneous Basal and Squamous Cell Carcinomas.
Abdou AG; Eldien MM; Elsakka D
Int J Surg Pathol; 2015 Sep; 23(6):447-53. PubMed ID: 26092229
[TBL] [Abstract][Full Text] [Related]
9. The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.
Zhang X; Egawa K; Xie Y; Ihn H
Int J Dermatol; 2009 Jun; 48(6):579-83. PubMed ID: 19538364
[TBL] [Abstract][Full Text] [Related]
10. High numbers of human skin cancers express MMP2 and several integrin genes.
Orimoto AM; Neto CF; Pimentel ER; Sanches JA; Sotto MN; Akaishi E; Ruiz IR
J Cutan Pathol; 2008 Mar; 35(3):285-91. PubMed ID: 18251742
[TBL] [Abstract][Full Text] [Related]
11. Differential tissue and subcellular expressionof ERM proteins in normal and malignant tissues: cytoplasmic ezrin expression has prognostic signficance for head and neck squamous cell carcinoma.
Madan R; Brandwein-Gensler M; Schlecht NF; Elias K; Gorbovitsky E; Belbin TJ; Mahmood R; Breining D; Qian H; Childs G; Locker J; Smith R; Haigentz M; Gunn-Moore F; Prystowsky MB
Head Neck; 2006 Nov; 28(11):1018-27. PubMed ID: 16783828
[TBL] [Abstract][Full Text] [Related]
12. Expression of two androgen-induced proteins (pepsinogen C and apolipoprotein d) in epithelial skin cancers of the eyelids.
Alvarez ML; Barbón JJ; González LO; Lamelas ML; Vázquez J; Vizoso FJ
Ophthalmologica; 2004; 218(2):115-9. PubMed ID: 15004501
[TBL] [Abstract][Full Text] [Related]
13. Caveats in BerEP4 staining to differentiate basal and squamous cell carcinoma.
Yu L; Galan A; McNiff JM
J Cutan Pathol; 2009 Oct; 36(10):1074-176. PubMed ID: 19187107
[TBL] [Abstract][Full Text] [Related]
14. Expression of RPE65, a putative receptor for plasma retinol-binding protein, in nonmelanocytic skin tumours.
Hinterhuber G; Cauza K; Dingelmaier-Hovorka R; Diem E; Horvat R; Wolff K; Foedinger D
Br J Dermatol; 2005 Oct; 153(4):785-9. PubMed ID: 16181461
[TBL] [Abstract][Full Text] [Related]
15. Comparative analysis of immunohistochemical markers with invasiveness and histologic differentiation in squamous cell carcinoma and basal cell carcinoma of the skin.
Son KD; Kim TJ; Lee YS; Park GS; Han KT; Lim JS; Kang CS
J Surg Oncol; 2008 Jun; 97(7):615-20. PubMed ID: 18404670
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic analysis of the BRCA2 tumor suppressor gene region in cutaneous squamous cell carcinomas.
Gray SE; Kay E; Leader M; Mabruk M
J Cutan Pathol; 2008 Jan; 35(1):1-9. PubMed ID: 18095987
[TBL] [Abstract][Full Text] [Related]
17. Expression of class II beta-tubulin in non-melanoma cutaneous tumors.
Roh JY; Kee SH; Choi JW; Lee JH; Lee JH; Lee ES; Kim YS
J Cutan Pathol; 2007 Feb; 34(2):166-73. PubMed ID: 17244029
[TBL] [Abstract][Full Text] [Related]
18. Altered expression of ezrin in esophageal squamous cell carcinoma.
Zeng H; Xu L; Xiao D; Zhang H; Wu X; Zheng R; Li Q; Niu Y; Shen Z; Li E
J Histochem Cytochem; 2006 Aug; 54(8):889-96. PubMed ID: 16585385
[TBL] [Abstract][Full Text] [Related]
19. Prognostic implication of ezrin expression in esophageal squamous cell carcinoma.
Xie JJ; Xu LY; Wu ZY; Zhao Q; Xu XE; Wu JY; Huang Q; Li EM
J Surg Oncol; 2011 Oct; 104(5):538-43. PubMed ID: 21416469
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of sperm-associated antigen 9 in nonmelanoma skin cancer.
Seleit I; Bakry OA; Samaka RM; Malak MA
Am J Dermatopathol; 2015 Jan; 37(1):38-45. PubMed ID: 25033008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
